Amlitelimab, Amlitelimab matching placebo comprised of the same excipients as the Test product without the active substance
ACT17967
Phase 2 small_molecule active
Quick answer
Amlitelimab, Amlitelimab matching placebo comprised of the same excipients as the Test product without the active substance for Hidradenitis is a Phase 2 program (small_molecule) at Sanofi Pharma Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sanofi Pharma Bristol-Myers Squibb
- Indication
- Hidradenitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active